Cysteamine-pantetheine disulfide

cysteamine-pantetheine disulfide · Thiogenesis Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cysteamine-pantetheine disulfide, covering 2024-10-01 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19 [Phase 2]